Direxion Daily 20 Year Treasury Bull 3X Shares vs DENTSPLY SIRONA Inc — how do they compare? Direxion Daily 20 Year Treasury Bull 3X Shares trades at $30.74, while DENTSPLY SIRONA Inc trades at $11.34 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while Direxion Daily 20 Year Treasury Bull 3X Shares pays none, and DENTSPLY SIRONA Inc is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| TMF | XRAY | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $44.14 | $14.68 |
52-Week Low | $30.59 | $9.64 |
Market Cap | — | $2.31B |
Enterprise Value | — | $4.39B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
TMF, the Direxion Daily 20+ Year Treasury Bull 3X ETF, trades at $30.76, up 0.38% today, but technical indicators are predominantly bearish with moving averages signaling sell. Key financial ratios like P/E and P/S are unavailable, and the fund's leveraged structure amplifies volatility. Recent news highlights significant long-term losses, with a $10,000 investment five years ago now worth about $1,527, underscoring the risks of daily rebalancing.
The outlook for TMF is highly speculative, offering potential gains if long-term Treasury yields decline, but it carries extreme risk due to leverage decay and interest rate sensitivity. Investors should avoid long-term holdings, as the fund is suited only for short-term traders who can manage amplified losses. Macroeconomic shifts in bond markets remain the primary driver of performance.
DENTSPLY SIRONA (XRAY) trades at $11.40, down 2.23% amid ongoing revenue declines and negative profitability. The stock shows bearish technical signals with support at $11 and resistance at $12. Recent Q2 2026 earnings beat expectations with $0.52 EPS but revenue fell 4.1% year-over-year to $898 million, reflecting persistent challenges in dental markets. The company maintains a 'Hold' analyst consensus with a $11.50 price target while executing its turnaround strategy.
Investment outlook remains cautious given six consecutive quarters of revenue declines and negative net margins. The company's restructuring efforts and new CFO appointment offer potential for operational improvement, but weak European demand and competitive pressures pose significant headwinds. With debt-to-asset ratio rising to 42.88% in 2025, financial leverage adds risk to the recovery thesis.
Trailing returns across standard periods
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →